Quantum Cat CVRP

Država: Velika Britanija

Jezik: angleščina

Source: VMD (Veterinary Medicines Directorate)

Aktivna sestavina:

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Dostopno od:

Intervet UK Ltd

Koda artikla:

QI06AD04

INN (mednarodno ime):

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Status dovoljenje:

Expired

Lastnosti izdelka

Revised: December 2010
AN: 01890/2009
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Quantum Cat CVRP
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE(S) PER DOSE (1 ML)
Live attenuated feline enteritis (panleucopaenia)
virus (FPV), Snow Leopard strain
10
3.0
CCID
50
*
Live attenuated feline rhinotracheitis
virus (FVR), strain FVRm,
10
5.0
CCID
50
*
Live attenuated Calicivirus (FCV), strain F9
10
5.5
CCID
50
*
*Cell culture infectious dose-50
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats from 9 weeks of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of cats to reduce mortality and clinical signs of
disease caused
by feline enteritis (panleucopaenia) virus, to reduce clinical signs
of disease caused
by feline rhinotracheitis virus and to prevent clinical signs of
disease and reduce
infection caused by feline calicivirus.
Onset of immunity occurs by approximately 3 weeks after the last dose
of the Basic
Vaccination Scheme.
The duration of immunity is at least 12 months.
4.3
CONTRA-INDICATIONS
Unhealthy animals should not be vaccinated.
Page 1 of 4
Revised: December 2010
AN: 01890/2009
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The feline panleucopaenia virus and the feline calicivirus vaccinal
strains may be
shed from vaccinated animals for a number of days following
vaccination.
However, due to the low pathogenicity of these strains, it is not
necessary to keep
vaccinated animals separated from non-vaccinated animals.
Moderate to high levels of maternally derived antibodies (MDA) may
interfere with
the response to vaccination.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
In case of accidental self-injection, wash the area immediately with
water. If
symptoms develop, seek medical att